Tags: Atectura® Breezhaler®, BioSyent Inc., CSE, Enerzair® Breezhaler®, HLS Therapeutics, investment, Knight Therapeutics, Medexus Pharmaceuticals, pharma
Agoracom Blog
AGORACOM Small Cap 60: How Big Is Valeo Pharma’s $VPH $VPHIF Commercialization and Supply Agreement With Novartis? $HLS.ca $MDP.ca $GUD.ca $RX.ca
Posted by
at 12:04 PM on Wednesday, March 31st, 2021